Author:
Persona Ernesto Pérez,Mesa Mercedes Gironella,Sánchez Pedro José García,Rodríguez Ana Pilar González
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference26 articles.
1. Kumar SK, Rajkumar SV, Dispenzieri A, et al. Improved survival in multiple myeloma and the impact of novel therapies. Blood. 2008;111:2516–2520.
2. Sirohi B, Powles R. Epidemiology and outcomes research for MGUS, myeloma and amyloidosis. Eur J Cancer. 2006;42:1671–1683.
3. Clinical Trials.gov: a service of the US National Institutes of Health. Search of studies with lenalidomide and newly diagnosed multiple myeloma. Available at: http://clinicaltrials.gov/ct2/results?term=lenalidomide+and+newly+diagnosed+multiple+myeloma . Accessed December 14, 2010.
4. Engelhardt M, Kleber M, Udi J, et al. Consensus statement from European experts on the diagnosis, management, and treatment of multiple myeloma: from standard therapy to novel approaches. Leuk Lymphoma. 2010;51:1424–1443.
5. Ludwig H, Beksac M, Bladé J, et al. Current multiple myeloma treatment strategies with novel agents: a European perspective. Oncologist. 2010;15:6–25.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献